Aspirin Dosing for Suspected Acute Stroke
For suspected acute ischemic stroke, administer a single loading dose of 160 mg aspirin immediately after intracranial hemorrhage has been ruled out on neuroimaging, followed by a maintenance dose of 81 mg daily.
Loading Dose
The most recent 2023 World Stroke Organization guidelines explicitly recommend 160 mg as a single loading dose for patients with acute ischemic stroke or TIA who were not previously on antiplatelet therapy 1. This must be administered only after:
- Intracranial hemorrhage is excluded on neuroimaging (CT or MRI)
- Dysphagia screening has been performed and passed
Critical Timing Considerations
- Aspirin should be given within 24-48 hours of symptom onset 2
- For patients who received IV thrombolysis (tPA), aspirin must be delayed until 24 hours after treatment and after follow-up imaging excludes hemorrhage 3, 2
- Recent research suggests aspirin at 18 hours post-thrombolysis may be safe, but the standard remains 24 hours 4
Maintenance Dose
Following the loading dose, continue with 81-325 mg daily indefinitely 1. The 2023 guidelines support a range, though 81 mg daily is increasingly preferred to minimize bleeding risk while maintaining efficacy.
Alternative Routes for Dysphagia
When swallowing is impaired 1:
- Rectal suppository: 325 mg daily
- Enteral tube: 81 mg daily
Special Populations
Minor Stroke (NIHSS ≤3) or High-Risk TIA
For these patients, dual antiplatelet therapy (DAPT) is superior to aspirin alone 1:
Loading doses:
- Aspirin: 160-325 mg
- Clopidogrel: 300-600 mg
Maintenance (for 21 days):
- Aspirin: 81 mg daily
- Clopidogrel: 75 mg daily
Then transition to single antiplatelet therapy.
Mild-Moderate Stroke (NIHSS ≤5)
Alternative DAPT regimen 1:
Loading doses:
- Aspirin: 300-325 mg
- Ticagrelor: 180 mg
Maintenance (for 30 days):
- Aspirin: 75-100 mg daily
- Ticagrelor: 90 mg twice daily
Important Caveats
Contraindications to immediate aspirin:
- Active intracranial hemorrhage on imaging
- Known aspirin allergy or severe intolerance
- Active major bleeding
- Patients already on therapeutic anticoagulation (requires individualized assessment)
Common Pitfall: Do not substitute aspirin for acute reperfusion therapies (IV tPA or mechanical thrombectomy) in eligible patients. Aspirin is not a substitute for these time-sensitive interventions 2.
Dosing Rationale: The 160 mg loading dose represents the lowest dose proven effective in large stroke trials while minimizing bleeding risk. Higher doses (300-325 mg) do not provide additional benefit and increase bleeding complications 1, 5, 6, 7. The 2018 AHA/ASA guidelines removed the specific "325 mg" recommendation because trials supporting aspirin use included doses of 160-300 mg with similar efficacy 2.
Evidence Quality: These recommendations are based on Class I, Level A evidence from large randomized trials and are consistently endorsed across multiple international stroke guidelines from 2023 1.